From: Is it time to use real-world data from primary care in Alzheimer’s disease?
Age group (years) | Cases | Population | Crude prevalence (95%CI) | Standardized prevalence (95%CI) | |
---|---|---|---|---|---|
All population | 65–69 | 1396 | 282,815 | 0.5 (0.5–0.5) | 0.5 (0.4-0.5)a |
70–74 | 3131 | 242,888 | 1.3 (1.2–1.3) | 1.3 (1.2–1.4)a | |
75–79 | 5885 | 179,329 | 3.3 (3.2–3.4) | 3.2 (3.0–3.4)a | |
80–84 | 11,402 | 171,494 | 6.6 (6.5–6.8) | 6.3 (6.1–6.6)a | |
85–89 | 11,381 | 110,530 | 10.3 (10.1–10.5) | 9.6 (9.3–10.0)a | |
≥ 90 | 6253 | 61,900 | 10.1 (9.9–10.3) | 9.1 (8.6–9.6)a | |
Total | 39,448 | 1,048,956 | 3.8 (3.7–3.8) | 3.1 (2.7–3.6)b | |
Women | 65–69 | 850 | 149,811 | 0.6 (0.5–0.6) | – |
70–74 | 1979 | 131,252 | 1.5 (1.4–1.6) | – | |
75–79 | 3864 | 100,054 | 3.9 (3.7–4.0) | – | |
80–84 | 8093 | 102,434 | 7.9 (7.7–8.1) | – | |
85–89 | 8496 | 71,533 | 11.9 (11.6–12.1) | – | |
≥ 90 | 5078 | 44,858 | 11.3 (11.0–11.6) | – | |
Total | 28,360 | 599,942 | 4.7 (4.7–4.8) | 3.8 (3.5–4.2)c | |
Men | 65–69 | 546 | 133,004 | 0.4 (0.4–0.4) | – |
70–74 | 1152 | 111,636 | 1.0 (1.0–1.1) | – | |
75–79 | 2021 | 79,275 | 2.5 (2.4–2.7) | – | |
80–84 | 3309 | 69,060 | 4.8 (4.6–5.0) | – | |
85–89 | 2885 | 38,997 | 7.4 (7.1–7.7) | – | |
≥ 90 | 1175 | 17,042 | 6.9 (6.5–7.3) | – | |
Total | 11,088 | 449,014 | 2.5 (2.4–2.5) | 2.4 (2.1–2.8)c |